The crucial role of mitochondrial impairments in PD pathogenesis was confirmed by experiments demonstrating a neuroprotective effect of coenzyme Q10, rapamycin, and the LRRK2 inhibitor GW5074 [121]. The gene discussed is LRRK2; the disease is Parkinson disease.